The Henry Ford + MSU Cancer Center is building a highly collaborative and integrated research enterprise designed to accelerate discoveries, transform patient care, and improve outcomes for the communities we serve. Through complementary scientific strengths and deep cross-disciplinary collaboration, our research programs span the continuum from fundamental cancer biology and population science to advanced engineering and quantitative modeling, all leading to translational therapeutics. Together, these programs create a dynamic ecosystem that advances innovation, fosters team science, and drives meaningful impact across cancer prevention, diagnosis, treatment, and survivorship.
The Cancer Biology & Immunology Program examines the molecular and cellular mechanisms of oncogenesis and tumor microenvironment to identify targets and biomarkers, leading to the development of novel therapeutics for cancer patients.
The Cancer Epidemiology, Prevention & Control Program aims to reduce the burden of cancer across Michigan through innovative research and interventions focused on multilevel drivers of cancer risk, precision cancer screening strategies, and cancer care across a diverse catchment area.
The Physical Sciences in Cancer Program develops and translates innovative quantitative approaches to advance cancer therapy, enhance tumor control, and improve patient outcomes.
Explore More of the Henry Ford + MSU Partnership